Analysis: Investment in biotech startups continues

10/9/2007 | Financial Times (free content)

With Big Pharma showing an interest in acquiring biotech startups to boost their pipelines amid upcoming patent expirations, venture capital backers are investing heavily in the startup biotech sector. However, if prices continue to rise for early-stage, risky products, partnerships may again become the preferred route to accessing new drugs for major drugmakers, this Financial Times analysis says.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA